Anacetrapib
≥99%
- Product Code: 77453
CAS:
875446-37-0
| Molecular Weight: | 637.51 g./mol | Molecular Formula: | C₃₀H₂₅F₁₀NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Anacetrapib is primarily investigated for its potential in cardiovascular disease management. It functions as a cholesteryl ester transfer protein (CETP) inhibitor, which helps in increasing high-density lipoprotein (HDL) cholesterol levels while reducing low-density lipoprotein (LDL) cholesterol. This dual action makes it a promising candidate for reducing the risk of heart attacks and strokes in patients with a history of cardiovascular issues. Clinical trials have explored its efficacy in combination with statins to further enhance cholesterol management. However, its development has faced challenges, including concerns about long-term safety and side effects, which have limited its widespread use. Research continues to evaluate its benefits and risks in specific patient populations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White to off-white solid |
| Purity | 98.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | $4,630.46 |
+
-
|
| 5mg | 10-20 days | $430.71 |
+
-
|
| 10mg | 10-20 days | $748.00 |
+
-
|
| 50mg | 10-20 days | $2,529.88 |
+
-
|
Anacetrapib
Anacetrapib is primarily investigated for its potential in cardiovascular disease management. It functions as a cholesteryl ester transfer protein (CETP) inhibitor, which helps in increasing high-density lipoprotein (HDL) cholesterol levels while reducing low-density lipoprotein (LDL) cholesterol. This dual action makes it a promising candidate for reducing the risk of heart attacks and strokes in patients with a history of cardiovascular issues. Clinical trials have explored its efficacy in combination with statins to further enhance cholesterol management. However, its development has faced challenges, including concerns about long-term safety and side effects, which have limited its widespread use. Research continues to evaluate its benefits and risks in specific patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :